216 related articles for article (PubMed ID: 8664119)
1. Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma.
Tsai JF; Jeng JE; Ho MS; Chang WY; Hsieh MY; Lin ZY; Tsai JH
Br J Cancer; 1996 Jun; 73(12):1498-502. PubMed ID: 8664119
[TBL] [Abstract][Full Text] [Related]
2. Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma.
Tsai JF; Chang WY; Jeng JE; Ho MS; Lin ZY; Tsai JH
J Med Virol; 1994 Sep; 44(1):92-5. PubMed ID: 7528262
[TBL] [Abstract][Full Text] [Related]
3. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan.
Yu MW; You SL; Chang AS; Lu SN; Liaw YF; Chen CJ
Cancer Res; 1991 Oct; 51(20):5621-5. PubMed ID: 1655259
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B e antigen and the risk of hepatocellular carcinoma.
Yang HI; Lu SN; Liaw YF; You SL; Sun CA; Wang LY; Hsiao CK; Chen PJ; Chen DS; Chen CJ;
N Engl J Med; 2002 Jul; 347(3):168-74. PubMed ID: 12124405
[TBL] [Abstract][Full Text] [Related]
5. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
6. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan.
Sun CA; Farzadegan H; You SL; Lu SN; Wu MH; Wolfe L; Hardy W; Huang GT; Yang PM; Lee H; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):173-8. PubMed ID: 8833617
[TBL] [Abstract][Full Text] [Related]
7. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Chinese: a case-control study.
Tsai JF; Jeng JE; Ho MS; Chang WY; Lin ZY; Tsai JH
Int J Cancer; 1994 Mar; 56(5):619-21. PubMed ID: 8314335
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus and HIV antibodies in patients with hepatocellular carcinoma in Zimbabwe: a pilot study.
Weinig M; Hakim JG; Gudza I; Tobaiwa O
Trans R Soc Trop Med Hyg; 1997; 91(5):570-2. PubMed ID: 9463670
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers.
Tseng TC; Liu CJ; Chen CL; Yang HC; Su TH; Wang CC; Yang WT; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
J Infect Dis; 2013 Aug; 208(4):584-93. PubMed ID: 23656977
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B and C virus and hepatocellular carcinoma.
Olubuyide IO; Aliyu B; Olalelye OA; Ola SO; Olawuyi F; Malabu UH; Odemuyiwa SO; Odaibo GN; Cook GC
Trans R Soc Trop Med Hyg; 1997; 91(1):38-41. PubMed ID: 9093625
[TBL] [Abstract][Full Text] [Related]
13. Epidemiologic assessment of interactions of hepatitis-C virus with seromarkers of hepatitis-B and -D viruses, cirrhosis and tobacco smoking in hepatocellular carcinoma.
Tzonou A; Trichopoulos D; Kaklamani E; Zavitsanos X; Koumantaki Y; Hsieh CC
Int J Cancer; 1991 Sep; 49(3):377-80. PubMed ID: 1655659
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma.
Liu J; Yang HI; Lee MH; Lu SN; Jen CL; Batrla-Utermann R; Wang LY; You SL; Hsiao CK; Chen PJ; Chen CJ;
Gut; 2014 Oct; 63(10):1648-57. PubMed ID: 24225939
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan.
Tsai JF; Chang WY; Jeng JE; Ho MS; Wang LY; Hsieh MY; Chen SC; Chuang WL; Lin ZY; Tsai JH
J Med Virol; 1993 Dec; 41(4):296-300. PubMed ID: 7508973
[TBL] [Abstract][Full Text] [Related]
16. Delta agent and the etiology of hepatocellular carcinoma.
Trichopoulos D; Day NE; Tzonou A; Hadziyannis S; Kaklamani E; Sparos L; Muñoz N; Hatzakis A
Int J Cancer; 1987 Mar; 39(3):283-6. PubMed ID: 3028967
[TBL] [Abstract][Full Text] [Related]
17. Seropositivity of hepatitis B e antigen and hepatocellular carcinoma.
You SL; Yang HI; Chen CJ
Ann Med; 2004; 36(3):215-24. PubMed ID: 15181977
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus e antigen and primary hepatocellular carcinoma.
Lin TM; Chen CJ; Lu SN; Chang AS; Chang YC; Hsu ST; Liu JY; Liaw YF; Chang WY
Anticancer Res; 1991; 11(6):2063-5. PubMed ID: 1663719
[TBL] [Abstract][Full Text] [Related]
19. The clinical and pathological features of hepatocellular carcinoma in Nnewi, Nigeria.
Okonkwo UC; Nwosu MN; Ukah C; Okpala OC; Ahaneku JI
Niger J Med; 2011; 20(3):366-71. PubMed ID: 21970220
[TBL] [Abstract][Full Text] [Related]
20. Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection.
Lee CM; Lu SN; Changchien CS; Yeh CT; Hsu TT; Tang JH; Wang JH; Lin DY; Chen CL; Chen WJ
Cancer; 1999 Oct; 86(7):1143-50. PubMed ID: 10506697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
